Insights

Industry Focus Expansion With its core focus on advancing cell and gene therapy technologies in the UK, the company presents a significant opportunity to provide specialized solutions such as clinical trial support, regulatory consulting, and manufacturing process innovations to biotech firms seeking to expand in this high-growth sector.

Strategic Partnerships Recent collaborations with organizations like CrownBio and The Crown Estate, along with partnerships in offshore wind and shipbuilding, indicate an openness to interdisciplinary ventures. Sales opportunities exist in offering cross-sector advanced manufacturing, infrastructure, and technical integration solutions to support these joint initiatives.

Leadership Growth New appointments of senior leaders such as the managing director and chief commercial officer underscore a strategic expansion and increased market ambitions, creating prospects to engage with senior management on tailored solutions that support organizational growth and market penetration.

Funding & Revenue Potential While currently generating revenues between $10M and $25M and receiving minimal funding of $1.5M, the company is poised for scaling, and sales efforts can focus on providing advanced digital technologies, grant consultancy, or R&D support to accelerate its growth trajectory.

Emerging Market Trends The company's involvement in offshore wind and renewable energy programmes highlights an interest in sustainable technologies. Sales opportunities exist in offering innovative engineering solutions, project management tools, or specialized software to support its involvement in these expanding markets.

Cell and Gene Therapy Catapult Tech Stack

Cell and Gene Therapy Catapult uses 8 technology products and services including Databricks, Microsoft Intune, Culture Amp, and more. Explore Cell and Gene Therapy Catapult's tech stack below.

  • Databricks
    Big Data Processing
  • Microsoft Intune
    Enterprise Mobility Management
  • Culture Amp
    Human Resource Management System
  • Mapbox GL JS
    Maps
  • SAP Maintenance, Repair, and Overhaul
    Operations
  • Proactis
    Procurement
  • Python
    Programming Languages
  • Workable
    Recruitment Marketing

Media & News

Cell and Gene Therapy Catapult's Email Address Formats

Cell and Gene Therapy Catapult uses at least 1 format(s):
Cell and Gene Therapy Catapult Email FormatsExamplePercentage
First.Last@ct.catapult.org.ukJohn.Doe@ct.catapult.org.uk
84%
FLast@ct.catapult.org.ukJDoe@ct.catapult.org.uk
13%
First.MiddleLast@ct.catapult.org.ukJohn.MichaelDoe@ct.catapult.org.uk
2%
First.Middle@ct.catapult.org.ukJohn.Michael@ct.catapult.org.uk
1%

Frequently Asked Questions

Where is Cell and Gene Therapy Catapult's headquarters located?

Minus sign iconPlus sign icon
Cell and Gene Therapy Catapult's main headquarters is located at London, England United Kingdom. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is Cell and Gene Therapy Catapult's official website and social media links?

Minus sign iconPlus sign icon
Cell and Gene Therapy Catapult's official website is ct.catapult.org.uk and has social profiles on LinkedInCrunchbase.

What is Cell and Gene Therapy Catapult's SIC code NAICS code?

Minus sign iconPlus sign icon
Cell and Gene Therapy Catapult's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cell and Gene Therapy Catapult have currently?

Minus sign iconPlus sign icon
As of April 2026, Cell and Gene Therapy Catapult has approximately 327 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Clinical Officer: J. B.Chief Technology Officer: S. W.Chief Operating Officer: E. S.. Explore Cell and Gene Therapy Catapult's employee directory with LeadIQ.

What industry does Cell and Gene Therapy Catapult belong to?

Minus sign iconPlus sign icon
Cell and Gene Therapy Catapult operates in the Biotechnology Research industry.

What technology does Cell and Gene Therapy Catapult use?

Minus sign iconPlus sign icon
Cell and Gene Therapy Catapult's tech stack includes DatabricksMicrosoft IntuneCulture AmpMapbox GL JSSAP Maintenance, Repair, and OverhaulProactisPythonWorkable.

What is Cell and Gene Therapy Catapult's email format?

Minus sign iconPlus sign icon
Cell and Gene Therapy Catapult's email format typically follows the pattern of First.Last@ct.catapult.org.uk. Find more Cell and Gene Therapy Catapult email formats with LeadIQ.

How much funding has Cell and Gene Therapy Catapult raised to date?

Minus sign iconPlus sign icon
As of April 2026, Cell and Gene Therapy Catapult has raised $1.5M in funding. The last funding round occurred on Jun 12, 2023 for $1.5M.

When was Cell and Gene Therapy Catapult founded?

Minus sign iconPlus sign icon
Cell and Gene Therapy Catapult was founded in 2012.

Cell and Gene Therapy Catapult

Biotechnology ResearchEngland, United Kingdom201-500 Employees

The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 300 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.
The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.

Section iconCompany Overview

Headquarters
London, England United Kingdom
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
201-500

Section iconFunding & Financials

  • $1.5M

    Cell and Gene Therapy Catapult has raised a total of $1.5M of funding over 5 rounds. Their latest funding round was raised on Jun 12, 2023 in the amount of $1.5M.

  • $10M$25M

    Cell and Gene Therapy Catapult's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $1.5M

    Cell and Gene Therapy Catapult has raised a total of $1.5M of funding over 5 rounds. Their latest funding round was raised on Jun 12, 2023 in the amount of $1.5M.

  • $10M$25M

    Cell and Gene Therapy Catapult's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

ยฉ LeadIQ, Inc. All rights reserved.